TSXV:ROOF
Trending >

ProMetic Life Sciences is a “dangerous” short but don’t go long, says EdgeHill’s Mann

ProMetic Life Sciences
ProMetic Life Sciences
EdgeHill Partners chief investment officer Jason Mann on BNN’s “Market Call” Tuesday.

Its share price has been falling steadily all year, but EdgeHill Partners chief investment officer Jason Mann thinks ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart, News: TSX:PLI) is still far from being a stock investors should be looking at.

Mann appeared on BNN’s “Market Call” Tuesday to talk about the once high-flying biotech. The portfolio manager says he has been short the stock but has recently covered because it has fallen “too far, too fast”. Mann says ProMetic’s business hasn’t unfolded the way management has wanted it to.

“It has always been an expensive stock and still is,” Mann says. “Negative ROE’s, there’s no cash flow, there’s no earnings to speak of, it’s incredibly volatile.”

The PM says he would, in fact, buy most any other stock before he would go long ProMetic.

“Unfortunately this stock scores in the bottom five per cent on every metric we look at,” he added. “Poor price momentum, (and) poor valuation because they are not yet a cash flowing entity. But it has fallen so far and is so volatile it becomes quite dangerous to stay short something like this. So we are nowhere on it, but it would be really difficult for me to recommend that someone step in and buy this here given the metrics that it shows.”

At press time, shares of ProMetic Life Sciences were down 4.9 per cent to $1.17.

More Cantech Life Sciences

  •  
  •  
  •  

About The Author /

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Comment

Leave a Reply

Your email address will not be published. Required fields are marked *